Honoring Salvador Luria, longtime MIT professor and founding director of the MIT Center for Cancer Research
Koch Institute event celebrates the new MIT Press biography “Salvador Luria: An Immigrant Biologist in Cold War America.”
Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
A new control system for synthetic genes
Researchers have developed a technique that could help fine-tune the production of monoclonal antibodies and other useful proteins.
Angela Koehler takes on the most challenging drug targets
Using biological, chemical, and engineering tools, she has developed strategies to attack molecules once thought to be “undruggable.”
Two first-year students named Rise Global Winners for 2022
Now in its second year, the Rise program targets exceptional teenage scholars from around the world for their potential as future change-makers.
A “door” into the mitochondrial membrane
Study finds the protein MTCH2 is responsible for shuttling various other proteins into the membrane of mitochondria. The finding could have implications for cancer treatments and MTCH2-linked conditions.
MIT biologist Richard Hynes wins Lasker Award
Hynes and two other scientists will share the prize for their discoveries of proteins critical for cellular adhesion.
Through mentorship, a deeper understanding of brain cancer metabolism grows
As an MSRP-Bio student in the Vander Heiden lab, Alejandra Rosario helped to reveal how cancer cells maintain access to materials they need to grow.
Using machine learning to identify undiagnosable cancers
A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.
How different cancer cells respond to drug-delivering nanoparticles
The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer.
Microparticles could be used to deliver “self-boosting” vaccines
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
How a shape-shifting receptor influences cell growth
Insight into the way the EGF receptor sends signals into cells could help researchers design new cancer drugs that target this protein.
Startup lets doctors classify skin conditions with the snap of a picture
Piction Health, founded by Susan Conover SM ’15, uses machine learning to help physicians identify and manage skin disease.
New model helps identify mutations that drive cancer
The system rapidly scans the genome of cancer cells, could help researchers find targets for new drugs.
Engineers develop nanoparticles that cross the blood-brain barrier
Tested using a new brain tissue model, the particles may be able to deliver chemotherapy drugs for glioblastoma.